Daniel Hirschhorn

4PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Jun 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|May 23, 2022
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions.

Sara E Schad, Andrew Chow, Levi Mangarin

Pageof 1

Frequent Collaborators

4 joint publications

Taha Merghoub

4 joint publications

Jedd D Wolchok

3 joint publications

Yacine Marouf

3 joint publications

Nicholas Ceglia

3 joint publications

Sadna Budhu

2 joint publications

Levi Mangarin

2 joint publications

Isabell Schulze

2 joint publications

Olivier Elemento

1 joint publications

Andrew Chow

1 joint publications

Jiajia Zhang

Frequent Collaborators

4 joint publications

Taha Merghoub

4 joint publications

Jedd D Wolchok

3 joint publications

Yacine Marouf

3 joint publications

Nicholas Ceglia

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us